You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen

Showing 1 - 25 of 2,303
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial (iMAB, cMAB)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jul 26, 2023

Aqueous Tear Deficiency, Meibomian Gland Dysfunction of Bilateral Eyes (Disorder) Trial in Fullerton (Testosterone gel 4.5%,

Recruiting
  • Aqueous Tear Deficiency
  • Meibomian Gland Dysfunction of Bilateral Eyes (Disorder)
  • Testosterone gel 4.5%
  • Vehicle gel
  • Fullerton, California
    Southern California College of Optometry at Marshall B. Ketchum
Nov 29, 2023

Radiotherapy and Androgen Deprivation In Combination After Local

Not yet recruiting
  • Prostate Cancer
  • Luteinising Hormone-Releasing Factor Analogue
  • (no location specified)
Nov 16, 2023

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Androgen deprivation therapy (ADT)
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023

Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)

Not yet recruiting
  • Prostate Cancer
  • Apalutamide Oral Product
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Mar 27, 2023

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Androgen suppression plus radiation therapy
  • Montreal, Quebec, Canada
  • +1 more
Jan 30, 2023

Polycystic Ovary Syndrome, Puberty Disorders, Ovulation Disorder Trial in Charlottesville (Spironolactone)

Recruiting
  • Polycystic Ovary Syndrome
  • +2 more
  • Charlottesville, Virginia
    University of Virginia Center for Research in Reproduction
Jul 28, 2022

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Adenocarcinoma of the Prostate Trial in Washington, Baltimore, Bethesda (Radiation Therapy, Androgen Deprivation Therapy (ADT))

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Radiation Therapy
  • Androgen Deprivation Therapy (ADT)
  • Washington, District of Columbia
  • +2 more
Oct 25, 2022

Predicting Cognitive Decline From Androgen Deprivation Therapy

Not yet recruiting
  • Prostate Cancer
  • Blood-based assay
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Apr 20, 2023

Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • triptorelin, goserelin, leuprorelin
  • (no location specified)
Mar 10, 2023

Androgen Metabolism, Metabolic Disease and Skeletal Muscle

Not yet recruiting
  • Hypogonadism, Male
  • +10 more
  • Dublin 9, Ireland
    Beaumont Hospital
Mar 16, 2023

Natural History Study of Patients With Excess Androgen

Recruiting
  • Congenital Adrenal Hyperplasia (CAH)
  • Familial Male-Limited Precocious Puberty (FMPP)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Castration Sensitive Prostate Cancer Trial in Little Rock (Metformin, Turmeric)

    Not yet recruiting
    • Castration Sensitive Prostate Cancer
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 12, 2023

    Androgen Deprivation Therapy, Prostate Cancer, Prostate Cancer Metastatic Trial in Boston (Aerobic and resistance exercise,

    Recruiting
    • Androgen Deprivation Therapy
    • +2 more
    • Aerobic and resistance exercise
    • Usual Care
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Oct 4, 2022

    Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

    Recruiting
    • Prostate Cancer
    • Prostate Disease
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 11, 2022

    Polycystic Ovary Syndrome, Androgen Excess, Metabolic Disease Trial in Dublin (Bicalutamide 50 mg)

    Not yet recruiting
    • Polycystic Ovary Syndrome
    • +2 more
    • Bicalutamide 50 mg
    • Dublin, Ireland
      Royal Collage Of Surgeons
    Dec 2, 2022

    Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

    Active, not recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • Charlotte, North Carolina
      Levine Cancer Institute
    Jan 12, 2023

    Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

    Not yet recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
    • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 4, 2023

    Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

    Recruiting
    • Salivary Gland Carcinoma
    • Chicago, Illinois
    • +6 more
    Sep 22, 2022